Gerogianni I., Pitaraki E., Jagirdar R.M., Kouliou O., Giannakou L., Giannopoulos S., Papazoglou E., Hatzoglou C., Gourgoulianis K.I., Zarogiannis S.G. (2019)
Background/Aim: Malignant pleural mesothelioma (MPM) is a therapy-resistant neoplasm of the pleura. Standard chemotherapy consists of a combination of cisplatin (CPDD) and pemetrexed (PEM). The aim of this study was to ...